Reata Pharma
(RETA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 76,881 | -116,117 | -311,901 | -226,399 | -147,397 |
| Depreciation Amortization | -4,003 | -1,666 | -2,177 | -337 | 234 |
| Accounts receivable | -22,662 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,009 | -4,355 | 5,201 | -6,215 | -5,756 |
| Other Working Capital | -11,067 | -12,741 | 9,309 | -1,671 | -9,600 |
| Other Operating Activity | -191,535 | 53,430 | 95,301 | 80,781 | 55,212 |
| Operating Cash Flow | $-151,377 | $-81,449 | $-204,267 | $-153,841 | $-107,307 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 372,420 | 175,000 | 320,000 | 75,000 | 0 |
| PPE Investments | -415 | -141 | -3,270 | -2,903 | -2,562 |
| Purchase Of Investment | -303,956 | -63,864 | -661,894 | -477,767 | -333,970 |
| Investing Cash Flow | $68,049 | $110,995 | $-345,164 | $-405,670 | $-336,532 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 72,564 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 17,684 | 13,082 | 1,485 | 1,171 | 735 |
| Other Financing Activity | -389 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $89,859 | $13,082 | $1,485 | $1,171 | $735 |
| Beginning Cash Position | 42,312 | 42,312 | 590,258 | 590,258 | 590,258 |
| End Cash Position | 48,843 | 84,940 | 42,312 | 31,918 | 147,154 |
| Net Cash Flow | $6,531 | $42,628 | $-547,946 | $-558,340 | $-443,104 |
| Free Cash Flow | |||||
| Operating Cash Flow | -151,377 | -81,449 | -204,267 | -153,841 | -107,307 |
| Capital Expenditure | -415 | -141 | -3,270 | -2,903 | -2,562 |
| Free Cash Flow | -151,792 | -81,590 | -207,537 | -156,744 | -109,869 |